The Quatro Study

Phase:Open Label
Principal Investigator(s):Jill Schwartz, MD, MPH
Objective:The Quatro Study will inform ongoing product development efforts, as well as expand upon the findings of the ASPIRE and Ring study results, by gathering end-user input that is both qualitative and quantitative. Quatro is the first acceptability study that will assess preferences and user experiences of four vaginal delivery systems developed for HIV and multipurpose prevention in the population most at risk for HIV, young women. So named for the four products that will be evaluated during the course of the study, Quatro will have women assess a rapidly disintegrating vaginal insert, an intravaginal ring (IVR), a vaginally inserted film and a vaginal gel. All are placebos and contain no active ingredients.
Prevention Option(s):Microbicides
Study Design:Open label, Randomized
Official Code: NCT02602366
Trial Sponsors: CONRAD
Start Date
End Date
November 11, 2015
May 3, 2018
Age range: 18 Years ↔ 30 Years
Population:Cisgender Women